These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges. Short NJ; Konopleva M; Kadia TM; Borthakur G; Ravandi F; DiNardo CD; Daver N Cancer Discov; 2020 Apr; 10(4):506-525. PubMed ID: 32014868 [TBL] [Abstract][Full Text] [Related]
10. New treatment for acute myelogenous leukemia. DiNardo CD; Cortes JE Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777 [TBL] [Abstract][Full Text] [Related]
11. Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine. Visani G; Olivieri A; Malagola M; Brunori M; Piccaluga PP; Capelli D; Pomponio G; Martinelli G; Isidori A; Sparaventi G; Leoni P Leuk Lymphoma; 2006 Jun; 47(6):1091-102. PubMed ID: 16840201 [TBL] [Abstract][Full Text] [Related]
12. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963 [TBL] [Abstract][Full Text] [Related]
14. Late-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia. Jamieson K; Odenike O Expert Opin Pharmacother; 2012 Oct; 13(15):2171-87. PubMed ID: 22971003 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group. Ettinger LJ; Ivy P; Gaynon PS; Ettinger AG; Liu-Mares W; Krailo MD Cancer; 1997 Jul; 80(2):311-6. PubMed ID: 9217045 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis targeted therapies in acute myeloid leukemia: an update. Ball S; Borthakur G Expert Rev Hematol; 2020 Dec; 13(12):1373-1386. PubMed ID: 33205684 [No Abstract] [Full Text] [Related]
17. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Bross PF; Beitz J; Chen G; Chen XH; Duffy E; Kieffer L; Roy S; Sridhara R; Rahman A; Williams G; Pazdur R Clin Cancer Res; 2001 Jun; 7(6):1490-6. PubMed ID: 11410481 [TBL] [Abstract][Full Text] [Related]
18. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301 [TBL] [Abstract][Full Text] [Related]
19. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cooper TM; Franklin J; Gerbing RB; Alonzo TA; Hurwitz C; Raimondi SC; Hirsch B; Smith FO; Mathew P; Arceci RJ; Feusner J; Iannone R; Lavey RS; Meshinchi S; Gamis A Cancer; 2012 Feb; 118(3):761-9. PubMed ID: 21766293 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Ravindranath Y Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]